FDA seeks safer drugs and biologics

被引：0

|

作者：

Wechsler, Jill ^{[1
]}

机构：

[1] Biopharm, Chevy Chase, MD 20815 USA

来源：

BIOPHARM INTERNATIONAL | 2007年 / 20卷 / 03期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：24 / +

页数：2

相关论文

共 50 条

[31] FDA Seeks Transparency in Data and Decisions
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2010, 23 (07) : 18 - 19
[32] FDA seeks input from stakeholders
Nightingale, SL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (10): : 872 - 872
[33] FDA SEEKS DIOXIN RISK COMMENTS
GASCH, M
PIMA MAGAZINE, 1994, 76 (08): : 16 - 16
[34] FDA SEEKS INPUT ON FEES FOR BIOSIMILARS
不详
CHEMICAL & ENGINEERING NEWS, 2011, 89 (20) : 27 - 27
[35] FDA seeks to close xenotransplant gap
MacIlwain, C
NATURE, 1997, 388 (6641) : 411 - 411
[36] FDA seeks comment on food safety
Nachay, Karen
FOOD TECHNOLOGY, 2011, 65 (07) : 12 - 12
[37] FDA seeks ideas for fighting Salmonella
Bartelme, Melanie Zanoza
FOOD TECHNOLOGY, 2014, 68 (10) : 12 - 12
[38] FDA seeks to close xenotransplant gap
Colin Macilwain
Nature, 1997, 388 : 411 - 411
[39] FDA seeks comments on compounding guide
Young, D
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (14) : 1318 - 1318
[40] The FDA and follow-on biologics - Navigating the issues surrounding biologics & likely outcome of FDA generic deliberation
Romza-Kutz, DJ
GENETIC ENGINEERING NEWS, 2006, 26 (06): : 8 - 9

← 1 2 3 4 5 →